Survivin and other IAP's have been reported to be upregulated in several malignancies, including breast cancer (Kawasaki et al, 1998; Lu et al, 1998; Monzo et al, 1999; Saitoh et al, 1999; Tanaka et al, 2000), compared to normal tissue. Here, BIRC5 is linked to breast carcinoma.